Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A...

Area of Science:

• Oncology
• Bioinformatics
• Artificial Intelligence in Medicine

Background:

• Neuroblastoma (NB) is a significant pediatric cancer with poor survival rates for high-risk metastatic tumors.
• Machine learning (ML) offers powerful tools for analyzing complex patient data in NB research.
• Existing literature utilizes ML for clinical and biological insights, but a comprehensive summary is needed.

Purpose of the Study:

• To systematically review and summarize literature employing ML and statistical methods for NB data analysis.
• To highlight the application of ML in predicting clinical outcomes, including risk stratification, survival, and treatment response.
• To provide a resource for future diagnostic and therapeutic efforts in NB.

Main Methods:

• Literature search and systematic review of studies using ML and statistical methods on NB data.
• Analysis of diverse data types including multi-omics, histology, and medical imaging.
• Categorization of studies based on their application in risk stratification and outcome prediction.

Main Results:

• Machine learning models are increasingly used to analyze multi-omics, imaging, and clinical data in neuroblastoma.
• These models demonstrate potential in stratifying patients into risk groups and predicting survival and treatment efficacy.
• Expression-based predictor models and ML are key for advancing NB patient management.

Conclusions:

• A comprehensive understanding of ML applications in NB is crucial for improving patient outcomes.
• Future research should focus on refining ML models for more accurate risk stratification and personalized treatment strategies.
• This review serves as a guide for leveraging ML in neuroblastoma research and clinical practice.